Open Access
E3S Web Conf.
Volume 251, 2021
2021 International Conference on Tourism, Economy and Environmental Sustainability (TEES 2021)
Article Number 02046
Number of page(s) 4
Section Environmental Ecological Analysis and Sustainable Development Research
Published online 15 April 2021
  1. Ann M.O., Fergus S. The gut flora as a forgotten organ. EMBO reports, 2006, 7(7): 688–693. [Google Scholar]
  2. Wang Z., Klipfell E., Bennett B.J., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease[J]. Nature, 2011, 472(7341):57–63. [Google Scholar]
  3. Davila J.A., El-Serag H. The Rising Incidence of Hepatocellular Carcinoma in the United States: an Update[J]. Gastroenterology, 2012, 142(5):S-914–S-914. [Google Scholar]
  4. Luca D.T., Angelo S., Mauro B., et al. Advanced precancerous lesionsin the liver [J]. Best Practice R esearch Clinical Gzstroenterology 2013, 27(2): 269–284. [Google Scholar]
  5. Milosericl I., Vujovic A., Barac A., et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. International Journal of Molecular Sciences, 20.2 (2019): 395. [Google Scholar]
  6. Jorge H.M., Eran E., Chengcheng J., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature, 2012, 482: 179–185. [Google Scholar]
  7. Kouichi M., Hirohide O. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol, 2014, 20: 7381–7391. [Google Scholar]
  8. Fredrik B., Ruth E.L., Justin L.S., et al. Host-bacterial mutualism in the human intestine. Science, 2005, 307(5717): 1915–1920. [Google Scholar]
  9. Andrew S.N. Microbes in gastrointestinal health and disease. Gastroenterology, 2009, 136(1): 65–80. [Google Scholar]
  10. Gill S.R., Pop M., DeBoy R.T., et al. Metagenomic analysis of the human distal gut microbiome. Science, 2006, 312: 1355–1359. [Google Scholar]
  11. Ramakrishna B., Krishnan S. The normal bacterial flora of the human intestine and its regulation. Journal of Clinical Gastroenterology, 2007, 41(Supplement 1): S2–S6. [Google Scholar]
  12. Daniel N.F., Allison L.S.A., Robert A.F., et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA, 2007, 104: 13780–13785. [Google Scholar]
  13. Junjie Q., Ruiqiang L., Jeroen R., et al. A human gut microbial gene catalogue established by metagenomics by metagenomics sequencing[J]. Nature, 2010, 464 (7285): 59–65. [Google Scholar]
  14. Sebastian D., Juan J., Sanchez S., et al. From the intestinal flora to the microbiome[J]. Rev Esp Enferm Dig, 2018, 110(1): 51 [Google Scholar]
  15. Sharon G., Garg N., Debelius J., et al. Specialized metabolites from the microbiome in health and disease[J]. Cell Metab, 2014, 20 (5): 719–730. [Google Scholar]
  16. Weitkunat K., Stuhlmann C., Postel A., et al. Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice[J]. Sci Rep, 2017, 7(1): 6109. [Google Scholar]
  17. Suchira G., Elena K., Mathias H., et al. When Soluble Fibers Meet Hepatocellular Carcinoma: The Dark Side of Fermentation[J]. Cell Metab, 2018, 28(5): 673–675. [Google Scholar]
  18. Zhi Y.K., Sunil K.L. The Human Gut Microbiome—A Potential Controller of Wellness and Disease[J]. other, 2018, 9: 1835. [Google Scholar]
  19. Pietro V., Giulia P., Alessio F. Microbiota and gut-liver axis: A mini-review on their influences on obesity and obesity-related liver disease[J]. Journal of Pediatric Gastroenterology & Nutrition, 2013, 56(5): 461–468. [Google Scholar]
  20. Yiu J.H., Dorweiler B., Woo C.W. Interaction between gut microbiota and toll-like receptor: From immunity to metabolism[J]. Journal of Molecular Medicine, 2017, 95(1): 13–20 [Google Scholar]
  21. Marilia R.P., Benedetto M.C., Michele D.R., et al. Microbial Translocation in Chronic Liver Diseases[J]. International Journal of Microbiology, 2012, 2012(2):694629. [Google Scholar]
  22. Bajaj J.S., Heuman D.M., Hylemon P.B., et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications[J]. Journal of Hepatology, 2014, 60(5): 940–947. [Google Scholar]
  23. Ekihiro S., Bernd S. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut[J]. Journal of Physiology, 2012, 590(3): 447–458. [Google Scholar]
  24. Dupont A.W., Dupont H.L. The intestinal microbiota and chronic disorders of the gut[J]. Nature Reviews Gastroenterology & Hepatology, 2011, 8(9): 523–531. [Google Scholar]
  25. Chen Y., Yang F., Lu H., et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology, 2011, 54: 562–572. [Google Scholar]
  26. Haifeng L., Zhongwen W., Wei X., et al. Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection[J]. Microbial Ecology, 2011, 61(3): 693–703. [Google Scholar]
  27. Daniel B., Reiner W. Gut microbiome and intestinal barrier failure--the “Achilles heel” in hepatology? [J]. Journal of Hepatology, 2012, 56(6): 1221–1223. [Google Scholar]
  28. Brandi G., De L., Candela M., et al. Microbiota, NASH, HCCand the potential role of probiotics[J]. Carcinogenesis, 2017, 38(3):231–240. [Google Scholar]
  29. Yu L.X., Schwabe R.F. The gut microbiome and liver cancer: mecha-nisms and clinical translation[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(9):527–539. [Google Scholar]
  30. Lijun W., Yujui Y.W. The role of gut microbiota in liver disease devel-opment and treatment[J]. Liver Res, 2019, 3(1): 3–18. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.